The Rheumatologist
COVID-19 News
  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed
  • Home
  • Conditions
    • Rheumatoid Arthritis
    • SLE (Lupus)
    • Crystal Arthritis
      • Gout Resource Center
    • Spondyloarthritis
    • Osteoarthritis
    • Soft Tissue Pain
    • Scleroderma
    • Vasculitis
    • Systemic Inflammatory Syndromes
    • Guidelines
  • Resource Centers
    • Axial Spondyloarthritis Resource Center
    • Gout Resource Center
    • Psoriatic Arthritis Resource Center
    • Rheumatoid Arthritis Resource Center
    • Systemic Lupus Erythematosus Resource Center
  • Drug Updates
    • Biologics & Biosimilars
    • DMARDs & Immunosuppressives
    • Topical Drugs
    • Analgesics
    • Safety
    • Pharma Co. News
  • Professional Topics
    • Ethics
    • Legal
    • Legislation & Advocacy
    • Career Development
      • Certification
      • Education & Training
    • Awards
    • Profiles
    • President’s Perspective
    • Rheuminations
    • Interprofessional Perspective
  • Practice Management
    • Billing/Coding
    • Quality Assurance/Improvement
    • Workforce
    • Facility
    • Patient Perspective
    • Electronic Health Records
    • Apps
    • Information Technology
    • From the College
    • Multimedia
      • Audio
      • Video
  • Resources
    • Issue Archives
    • ACR Convergence
      • Systemic Lupus Erythematosus Resource Center
      • Rheumatoid Arthritis Resource Center
      • Gout Resource Center
      • Abstracts
      • Meeting Reports
      • ACR Convergence Home
    • American College of Rheumatology
    • ACR ExamRheum
    • Research Reviews
    • ACR Journals
      • Arthritis & Rheumatology
      • Arthritis Care & Research
      • ACR Open Rheumatology
    • Rheumatology Image Library
    • Treatment Guidelines
    • Rheumatology Research Foundation
    • Events
  • About Us
    • Mission/Vision
    • Meet the Authors
    • Meet the Editors
    • Contribute to The Rheumatologist
    • Subscription
    • Contact
  • Advertise
  • Search
You are here: Home / Articles / 2022 PFS Final Rule for the Quality Payment Program Published

2022 PFS Final Rule for the Quality Payment Program Published

December 2, 2021 • By From the College

  • Tweet
  • Email
Print-Friendly Version / Save PDF

On Nov. 2, the Centers for Medicare & Medicaid Services (CMS) published the CY 2022 Medicare Physician Fee Schedule (PFS) Final Rule, which includes the final policies for the 2022 performance year of the Quality Payment Program (QPP).

You Might Also Like
  • 2022 Proposed Rule for the Quality Payment Program Released
  • Quality Payment Program 2021 Final Rule Released
  • CMS Releases 2021 Proposed Rule for the Quality Payment Program
Also By This Author
  • Coding Corner Answer: An Insurance Billing Quiz

The changes to performance category weighting and performance thresholds are in line with MACRA legislation requirements for the 2022 performance year. Included in the final rule are details for MIPS Value Pathway (MVP) scoring and the first list of approved MVPs for the 2023 performance year, including a rheumatology MVP submitted by the ACR. Notably, the CMS is also thinking of sunsetting traditional MIPS by the end of the 2027 MIPS performance year/2029 MIPS payment year in favor of MVP and Alternative Payment Model (APM) participation. Lastly, a major takeaway is that avoiding a penalty in MIPS will become harder, because the performance threshold will be increased to 75 points and quality bonus points will be removed.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

The ACR RISE registry staff reviewed the final rule and highlight below critical policy changes for the 2022 MIPS reporting period. You are also encouraged to check out the ACR Overview of 2022 Medicare Physician Fee Schedule Final Rule. If you have questions or concerns about how these proposed changes may affect your practice, contact RISE staff at [email protected].

Performance Category Weights

  • Quality: 30% for PY 2022 (40% for PY 2021)
  • Cost: 30% for PY 2022 (20% for PY 2021)
  • Promoting Interoperability: 25% for PY 2022 (no change from PY 2021)
  • Improvement Activities: 15% for PY 2022 (no change from PY 2021)

Performance Thresholds

  • Performance threshold: 75 points (60 points for CY 2021)
  • Additional performance threshold for exceptional performance: 89 points (85 points for CY 2021)

The CMS notes that the 2022 performance year/2024 payment year is the final year for an additional performance threshold/additional MIPS adjustment for exceptional performance.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

Quality Performance Category

Beginning with the 2022 performance period, there are no bonus points for reporting additional outcome and high priority measures beyond the one required. In addition, there are no bonus points for measures that meet end-to-end electronic reporting criteria.

The CMS will also remove the three-point floor for scoring measures, with some exceptions for small practices, beginning with the 2023 performance period. Lastly, the CMS updated the quality measure inventory, and there are a total of 200 quality measures available for the 2022 performance period.

Quality Performance Category Collection Types

ad goes here:advert-3
ADVERTISEMENT
SCROLL TO CONTINUE

The CMS is extending the CMS Web Interface as a collection type and submission type in traditional MIPS for registered groups, virtual groups and APM Entities with 25 or more clinicians for the 2022 performance year.

Quality Measure Benchmarks

After analyzing the available data, the CMS determined there was no need to use performance benchmarks exclusively or to use a different baseline period (such as CY 2019) to create historical benchmarks. The CMS will create historical benchmarks for the 2022 performance period, using data submitted for the 2020 performance period.

Improvement Activities Performance Category

The CMS is:

  • Adding seven new improvement activities, three of which are related to promoting health equity
  • Modifying 15 current improvement activities, 11 of which address health equity
  • Removing six previously adopted improvement activities

Promoting Interoperability Performance Category

Public Health and Clinical Data Exchange Objective

The CMS is modifying the reporting requirements for the Public Health and Clinical Data Exchange Objective and requiring MIPS-eligible clinicians to report the following two measures (unless an exclusion can be claimed):

  • Immunization Registry Reporting
  • Electronic Case Reporting

Beginning with the 2022 performance period, the following measures are optional; clinicians, groups and virtual groups that report a “yes” response for any of these measures will earn five bonus points:

  • Public Health Registry Reporting measure
  • Clinical Data Registry Reporting measure
  • Syndromic Surveillance Reporting measure

Promoting Interoperability Measures

  • The CMS did not finalize the proposal to modify the Provide Patients Electronic Access to Their Health Information measure to require patient health information to remain available to the patient (or patient-authorized representative) indefinitely, starting with a date of service of Jan. 1, 2016.
  • The Safety Assurance Factors for EHR Resilience Guides (SAFER Guides) is a new, required measure in which MIPS-eligible clinicians must attest to conducting an annual assessment of the High Priority Guide of the SAFER Guides.
  • For the Electronic Case Reporting measure, the CMS is adding a fourth exclusion (in addition to the existing exclusion criteria) for PY 2022 only: Uses certified electronic health record technology (CEHRT) that isn’t certified to the electronic case reporting certification criterion at 45 CFR 170.315(f)(5) prior to the start of the performance period they select in CY 2022.

Attestations

The CMS modified the required Prevention of Information Blocking attestation statements.

Promoting Interoperability Reweighting

In addition to the existing special statuses/clinician types, the CMS will apply automatic reweighting to the following, beginning with the 2022 performance period:

  • Small practices
  • Clinical social workers

Cost Performance Category

The CMS is adding five newly developed episode-based cost measures into the Cost performance category.

Data Completeness

The CMS is maintaining the current data completeness threshold at 70% for the 2022 and 2023 performance periods.

Redistributing Performance Category Weights for Small Practices

The CMS is finalizing the following performance category reweighting and redistribution policies for small practices to put more emphasis on the Improvement Activities performance category:

  • When the Promoting Interoperability performance category is reweighted:
    • The Quality performance category will be weighted at 40%;
    • The Cost performance category will be weighted at 30%; and
    • The Improvement Activities performance category will be weighted at 30%.
  • When both the Cost and the Promoting Interoperability performance categories are reweighted:
    • The Quality performance category will be weighted at 50%; and
    • The Improvement Activities performance category will be weighted at 50%.

Under the existing policies, when both Quality and the Promoting Interoperability performance categories are reweighted, the Cost and Improvement Activities performance categories will be equally weighted at 50%.

MIPS Value Pathways (MVPs)

One of the seven MVPs starting with the 2023 performance period/2025 MIPS payment year is Advancing Rheumatology Patient Care, created by the ACR. Through this MVP, rheumatology providers can choose among quality measures relevant to rheumatology and improvement activities that have been vetted by rheumatology experts.

The table below lists the measures and activities that are finalized within the Advancing Rheumatology Patient Care MVP.

Quality Improvement Activities Cost
Q111: Pneumococcal Vaccination Status for Older Adults IA_AHE_3: Promote use of Patient-Reported Outcome Tools Total Per Capita Cost (TPCC)
Q130: Documentation of Current Medications in the Medical Record IA_BE_4: Engagement of patients through implementation of improvements in patient portal  
Q176: Tuberculosis Screening Prior to First Course Biologic Therapy IA_BE_15: Engagement of patients, family and caregivers in developing a plan of care  
Q177: Rheumatoid Arthritis (RA): Periodic Assessment of Disease Activity IA_BMH_2: Tobacco use  
Q178: Rheumatoid Arthritis (RA): Functional Status Assessment IA_BMH_4: Depression screening  
Q180: Rheumatoid Arthritis (RA): Glucocorticoid Management IA_EPA_1: Provide 24/7 Access to MIPS Eligible Clinicians or Groups Who Have Real-Time Access to Patient’s Medical Record  
ACR12: Disease Activity Measurements for Patients with PsA IA_EPA_2: Use of telehealth services that expand practice access  
ACR14: Gout Serum Urate Target IA_PM_16: Implementation of medication management practice improvements  
ACR15: Safe Hydroxychloroquine Dosing IA_PSPA_6: Consultation of the Prescription Drug Monitoring Program  
  IA_PSPA_28: Completion of an Accredited Safety or Quality Improvement Program  

Additional Resources

These are key takeaways from the 2022 Final Rule; not all changes have been included in this overview. To learn more about the PFS Final Rule and the 2022 QPP finalized policies, review the following resources:

  • Press Release

    Provides additional details regarding the announcement.

  • 2022 Quality Payment Program Final Rule

    This is a link to the CY2022 Medicare Physician Fee Schedule (PFS) Final Rule.

  • 2022 Quality Payment Program Resources

    This zip file includes the 2022 QPP final rule overview fact sheet; a policy comparison table; MVPs policy table; a MVP development standardized template; and FAQs.

Questions?

Contact the Quality Payment Program at 1-866-288-8292 or by e-mail [email protected].

ACR RISE registry staff are also available to assist you with questions related to reporting for MIPS. Contact the RISE registry at 404-633-3777 or by email at [email protected].

Pages: 1 2 3 4 | Multi-Page

Filed Under: Quality Assurance/Improvement Tagged With: MIPS reporting, MIPS Value Pathways, Physician Fee Schedule (PFS), Quality Payment Program (QPP), Rheumatology Informatics System for Effectiveness (RISE) Registry

You Might Also Like:
  • 2022 Proposed Rule for the Quality Payment Program Released
  • Quality Payment Program 2021 Final Rule Released
  • CMS Releases 2021 Proposed Rule for the Quality Payment Program
  • CMS 2020 Quality Payment Program Proposed Rule Contains Key Changes to MIPS Reporting

Meeting Abstracts

Browse and search abstracts from the ACR Convergence and ACR/ARP Annual Meetings going back to 2012.

Visit the Abstracts site »

Rheumatology Research Foundation

The Foundation is the largest private funding source for rheumatology research and training in the U.S.

Learn more »

American College of Rheumatology

Visit the official website for the American College of Rheumatology.

Visit the ACR »

The Rheumatologist newsmagazine reports on issues and trends in the management and treatment of rheumatic diseases. The Rheumatologist reaches 11,500 rheumatologists, internists, orthopedic surgeons, nurse practitioners, physician assistants, nurses, and other healthcare professionals who practice, research, or teach in the field of rheumatology.

About Us / Contact Us / Advertise / Privacy Policy / Terms of Use

  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed

Copyright © 2006–2022 American College of Rheumatology. All rights reserved.

ISSN 1931-3268 (print)
ISSN 1931-3209 (online)

loading Cancel
Post was not sent - check your email addresses!
Email check failed, please try again
Sorry, your blog cannot share posts by email.